{"title":"The devil in the details—Unpacking functional recovery after ileal pouch-anal anastomosis","authors":"Xiaoyu Wang","doi":"10.1111/codi.70312","DOIUrl":"https://doi.org/10.1111/codi.70312","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 11","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145522039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Concerns on the statistical methodology and incomplete reporting of patient information in the long-term outcomes of biologic therapy for prepouch ileitis","authors":"Yuzhou Zhu, Ziqiang Wang","doi":"10.1111/codi.70309","DOIUrl":"https://doi.org/10.1111/codi.70309","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 11","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145522040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Improved outcomes after treatment for rectal cancer (RC) have resulted in more long-term survivors, some with a permanent colostomy. The challenges associated with a stoma may impact health-related quality of life (HRQoL) and change over time. We report changes in stoma-related sequelae and HRQoL from a prospective follow-up program.
Methods
Patients were included from a systematic late sequelae screening program using patient-reported outcome measures. Patients undergoing RC surgery with a permanent colostomy were included. Patients completed the colostomy impact (CI) score and EuroQol five-dimensional five-level (EQ-5D-5L) at 3, 12, 24 and 36 months after surgery. CI scores and mean EQ-5D-5L scores were compared, and multivariable regression analysis was performed to explore potential risk factors for major CI at 12 months.
Results
A total of 301 patients (34% female) were included, with a mean age of 71.2 years. Median CI scores, EQ-5D-5L index and EQ-5D-5L visual analogue scale scores remained unchanged. However, the distribution of the individual symptoms composing the CI score changed from 3 to 12 months, with more smell and leakage, more parastomal bulging and better self-care. Between 3 and 12 months, 27% of patients shifted CI category and around 20% of patients shifted category at 2 and 3 years post surgery. Logistic regression showed a significantly higher risk of major CI at 12 months in younger patients, patients with higher American Society of Anaesthesiologists scores, preoperative radiotherapy or postoperative complications.
Conclusion
Stoma-related sequelae change during the first years after surgery. However, this is not reflected in CI Score or generic HRQoL.
{"title":"Does the impact of a colostomy on quality of life change with time? – Prospective evaluation in rectal cancer patients","authors":"Helle Ø Kristensen, Peter Christensen, Ismail Gögenur, Karen Irene Jacobsen, Therese Juul, Sissel Ravn, Marianne Krogsgaard","doi":"10.1111/codi.70305","DOIUrl":"https://doi.org/10.1111/codi.70305","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>Improved outcomes after treatment for rectal cancer (RC) have resulted in more long-term survivors, some with a permanent colostomy. The challenges associated with a stoma may impact health-related quality of life (HRQoL) and change over time. We report changes in stoma-related sequelae and HRQoL from a prospective follow-up program.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Patients were included from a systematic late sequelae screening program using patient-reported outcome measures. Patients undergoing RC surgery with a permanent colostomy were included. Patients completed the colostomy impact (CI) score and EuroQol five-dimensional five-level (EQ-5D-5L) at 3, 12, 24 and 36 months after surgery. CI scores and mean EQ-5D-5L scores were compared, and multivariable regression analysis was performed to explore potential risk factors for major CI at 12 months.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 301 patients (34% female) were included, with a mean age of 71.2 years. Median CI scores, EQ-5D-5L index and EQ-5D-5L visual analogue scale scores remained unchanged. However, the distribution of the individual symptoms composing the CI score changed from 3 to 12 months, with more smell and leakage, more parastomal bulging and better self-care. Between 3 and 12 months, 27% of patients shifted CI category and around 20% of patients shifted category at 2 and 3 years post surgery. Logistic regression showed a significantly higher risk of major CI at 12 months in younger patients, patients with higher American Society of Anaesthesiologists scores, preoperative radiotherapy or postoperative complications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Stoma-related sequelae change during the first years after surgery. However, this is not reflected in CI Score or generic HRQoL.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 11","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145522038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ida Kaad Faurschou, Rune Erichsen, Dietrich Doll, Susanne Haas
Background
Acute abscess-forming pilonidal sinus disease (PSD) is treated surgically, with lateral incision and drainage (I&D) considered the gold standard; however, the risk of re-operation is unknown.
Aim
To evaluate re-operation rates following abscess-forming PSD treatment with lateral I&D, and to identify factors influencing re-operation rates.
Methods
Using data from nationwide Danish databases covering 2010–2021, we identified patients diagnosed with abscess-forming PSD undergoing lateral I&D as the initial treatment for PSD. Patients were followed up until re-operation, death, emigration, or the end of the study period. Stratified by sex, the risk of re-operation was reported as a cumulative incidence function (CIF). To explore risks, we used Cox regression analysis to calculate crude and age-adjusted hazard ratios (aHR).
Results
Of 8251 (62% male) patients included, 2455 underwent re-operation for PSD. The overall five-year CIF was 32% for males and 33% for females. In males, the five-year CIF decreased from 47% among 0- to 16-year-olds to 14% among 50+ year-olds. In females, the corresponding numbers were 37% and 13%, respectively. A family history of PSD was found to increase re-operation risk, especially among female patients (aHR: 1.64 (95% confidence interval [95% CI]: 1.39–1.93)). The risk increases following the second and third consecutive I&D procedures to 52% and 69% in males, and to 57% and 64% in females, respectively.
Conclusion
As roughly two-thirds of patients do not require additional surgery, our findings do not support mandatory follow-up with definitive surgery for all PSD patients undergoing I&D. For certain high-risk subgroups, however, subsequent definitive surgery may be appropriate.
{"title":"Risk of re-operation after incision and drainage for acute, abscess-forming pilonidal sinus disease: A Danish population-based cohort study","authors":"Ida Kaad Faurschou, Rune Erichsen, Dietrich Doll, Susanne Haas","doi":"10.1111/codi.70307","DOIUrl":"https://doi.org/10.1111/codi.70307","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Acute abscess-forming pilonidal sinus disease (PSD) is treated surgically, with lateral incision and drainage (I&D) considered the gold standard; however, the risk of re-operation is unknown.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>To evaluate re-operation rates following abscess-forming PSD treatment with lateral I&D, and to identify factors influencing re-operation rates.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Using data from nationwide Danish databases covering 2010–2021, we identified patients diagnosed with abscess-forming PSD undergoing lateral I&D as the initial treatment for PSD. Patients were followed up until re-operation, death, emigration, or the end of the study period. Stratified by sex, the risk of re-operation was reported as a cumulative incidence function (CIF). To explore risks, we used Cox regression analysis to calculate crude and age-adjusted hazard ratios (aHR).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 8251 (62% male) patients included, 2455 underwent re-operation for PSD. The overall five-year CIF was 32% for males and 33% for females. In males, the five-year CIF decreased from 47% among 0- to 16-year-olds to 14% among 50+ year-olds. In females, the corresponding numbers were 37% and 13%, respectively. A family history of PSD was found to increase re-operation risk, especially among female patients (aHR: 1.64 (95% confidence interval [95% CI]: 1.39–1.93)). The risk increases following the second and third consecutive I&D procedures to 52% and 69% in males, and to 57% and 64% in females, respectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>As roughly two-thirds of patients do not require additional surgery, our findings do not support mandatory follow-up with definitive surgery for all PSD patients undergoing I&D. For certain high-risk subgroups, however, subsequent definitive surgery may be appropriate.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 11","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145522041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gaurav R. Kumar, Karthikeyan Parthasarathy, Pavan Sugoor
{"title":"Laparoscopic right hemicolectomy with CME-CVL, with intracorporeal ileotransverse anastomosis using the ASPIRE technique – A video vignette","authors":"Gaurav R. Kumar, Karthikeyan Parthasarathy, Pavan Sugoor","doi":"10.1111/codi.70304","DOIUrl":"10.1111/codi.70304","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 11","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145494577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Paul F. Vollebregt, Yan Li Goh, Anil Bagul, Claire Chan, Tom Dudding, Paul Furlong, Shaheen Hamdy, Joanne Haviland, Richard Hooper, James Jones, Eleanor McAlees, Christine Norton, P. Ronan O'Connell, Michael Powar, S. Mark Scott, Natasha Stevens, Kerry Tubby, Sian Worthen, Yuk Lam Wong, Charles H. Knowles
Aim
Sacral neuromodulation (SNM) is considered the first-line surgical treatment in adults with refractory faecal incontinence (FI). However, its clinical efficacy has not been rigorously tested in a trial setting.
Method
Randomised, multicentre, double-blind crossover trial (two 16-week periods) of active stimulation versus sham, and open-label follow-up to 58 weeks. Participants: adults aged 18–80 with refractory FI. Interventions: Active: subsensory sacral nerve stimulation with an implanted pulse generator; Sham: identical implant but turned off. Primary outcome: FI episodes per week (paper bowel diary) during final 4 weeks of crossover periods (allowing 12 weeks' washout). Randomised allocation (1:1) to arm 1 (SNM/sham) or arm 2 (sham/SNM). Blinding: participants, surgeons, assessors; tamper-proof tape-masked stimulation settings. Sample size: 80 patients to detect a 30% reduction in episodes. Groups compared using a paired t-test, and treatment effects summarised by mean differences.
Results
Trial delivery was severely affected by COVID-19. Thirty-nine patients of 220 screened (arm 1: N = 17; arm 2: N = 22) were recruited at 10 sites (February 2018–July 2022), of whom only 16 (arm 1: N = 9; arm 2: N = 7) had complete primary outcome data. Of the 39, 19 completed follow-up to 58 weeks. SNM conferred a non-significant reduction in mean FI episodes per week compared to sham (−0.795 [95% CI: −1.5 to 0.0], p = 0.06). Improvements were observed in FI symptoms at 58 weeks compared to baseline (FI episodes per week: 3.2 [SD 3.3] vs. 6.2 [SD 5.9]).
Conclusions
The SUBSoNIC trial failed to find conclusive evidence of the experimental efficacy of SNM. Further demonstration of experimental efficacy remains important as SNM is a high-cost and invasive therapy.
{"title":"Clinical efficacy of subsensory sacral neuromodulation in adults with faecal incontinence: The SUBSoNIC crossover randomised controlled trial and cohort follow-up study","authors":"Paul F. Vollebregt, Yan Li Goh, Anil Bagul, Claire Chan, Tom Dudding, Paul Furlong, Shaheen Hamdy, Joanne Haviland, Richard Hooper, James Jones, Eleanor McAlees, Christine Norton, P. Ronan O'Connell, Michael Powar, S. Mark Scott, Natasha Stevens, Kerry Tubby, Sian Worthen, Yuk Lam Wong, Charles H. Knowles","doi":"10.1111/codi.70308","DOIUrl":"10.1111/codi.70308","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>Sacral neuromodulation (SNM) is considered the first-line surgical treatment in adults with refractory faecal incontinence (FI). However, its clinical efficacy has not been rigorously tested in a trial setting.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>Randomised, multicentre, double-blind crossover trial (two 16-week periods) of active stimulation versus sham, and open-label follow-up to 58 weeks. Participants: adults aged 18–80 with refractory FI. Interventions: <i>Active</i>: subsensory sacral nerve stimulation with an implanted pulse generator; <i>Sham</i>: identical implant but turned off. Primary outcome: FI episodes per week (paper bowel diary) during final 4 weeks of crossover periods (allowing 12 weeks' washout). Randomised allocation (1:1) to arm 1 (SNM/sham) or arm 2 (sham/SNM). Blinding: participants, surgeons, assessors; tamper-proof tape-masked stimulation settings. Sample size: 80 patients to detect a 30% reduction in episodes. Groups compared using a paired <i>t</i>-test, and treatment effects summarised by mean differences.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Trial delivery was severely affected by COVID-19. Thirty-nine patients of 220 screened (arm 1: <i>N</i> = 17; arm 2: <i>N</i> = 22) were recruited at 10 sites (February 2018–July 2022), of whom only 16 (arm 1: <i>N</i> = 9; arm 2: <i>N</i> = 7) had complete primary outcome data. Of the 39, 19 completed follow-up to 58 weeks. SNM conferred a non-significant reduction in mean FI episodes per week compared to sham (−0.795 [95% CI: −1.5 to 0.0], <i>p</i> = 0.06). Improvements were observed in FI symptoms at 58 weeks compared to baseline (FI episodes per week: 3.2 [SD 3.3] vs. 6.2 [SD 5.9]).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The SUBSoNIC trial failed to find conclusive evidence of the experimental efficacy of SNM. Further demonstration of experimental efficacy remains important as SNM is a high-cost and invasive therapy.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 11","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12605715/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145494644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comment on: Analysis of preoperative predictors for pouchitis after surgery for ulcerative colitis: A multicentre retrospective study of the clinical outcome of surgery for ulcerative colitis in Japan (COSUC study)","authors":"Yanqi Cheng, Dongmei Luo, Ying Sun","doi":"10.1111/codi.70306","DOIUrl":"10.1111/codi.70306","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 11","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145488122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Thalia Petropoulou, Jente Simoens, Andreas Polydorou, Pieter De Backer, Alex Mottrie
Artificial intelligence (AI) and augmented reality (AR) are transforming the landscape of minimally invasive surgery. We present the world's first live integration of an AI-assisted AR overlay with real-time instrument deocclusion in robotic colorectal surgery.
A real surgical case of robotic right colectomy was performed using a da Vinci Xi platform enhanced by an AI-driven AR system. The technology generated three-dimensional anatomical overlays while simultaneously applying instrument deocclusion algorithms to maintain continuous visualization of critical anatomy (Video 1).
The procedure was successfully completed without conversion, demonstrating the technical feasibility of combining AI-based overlays and deocclusion in a complex intraoperative environment. The system allowed stable AR guidance despite dynamic camera movements and instrument interference. From the operating surgeon's perspective, the AR overlay was useful, non-disruptive to workflow, and enhanced anatomical orientation. These impressions are preliminary and require validation in prospective studies.
This proof-of-concept highlights the feasibility of AI-assisted AR with instrument deocclusion in robotic colorectal surgery and represents an important step toward digital surgery of the future. While no formal outcomes or structured user assessments were collected in this initial demonstration, future studies will focus on systematic evaluation of usability, surgeon feedback, and clinical performance metrics.
Thalia Petropoulou: Conceptualization; investigation; writing – original draft; methodology; validation; visualization; writing – review and editing; formal analysis. Jente Simoens: Methodology; validation; software. Andreas Polydorou: Investigation; validation; supervision. Pieter De Backer: Conceptualization; methodology; validation; software; formal analysis; data curation. Alex Mottrie: Methodology; validation; software; supervision.
No funding was used.
No conflict of interest between the authors.
This study was conducted in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments.
人工智能（AI）和增强现实（AR）正在改变微创手术的格局。我们在机器人结肠直肠手术中展示了世界上第一个人工智能辅助AR覆盖与实时仪器去闭塞的实时集成。使用由人工智能驱动的AR系统增强的达芬奇Xi平台进行了一个真实的机器人右结肠切除术病例。该技术生成三维解剖叠加，同时应用器械去闭塞算法来保持关键解剖的连续可视化（视频1）。该手术成功完成，无需转换，证明了在复杂的术中环境下将基于ai的覆盖与去咬合相结合的技术可行性。该系统允许稳定的AR制导，尽管动态相机运动和仪器干扰。从外科医生的角度来看，AR覆盖是有用的，不会干扰工作流程，并增强了解剖方向。这些印象是初步的，需要在前瞻性研究中验证。这一概念验证强调了人工智能辅助AR在机器人结肠直肠手术中的可行性，并代表了未来数字化手术的重要一步。虽然在最初的演示中没有收集到正式的结果或结构化的用户评估，但未来的研究将集中在可用性、外科医生反馈和临床表现指标的系统评估上。Thalia Petropoulou：概念化；调查;写作——原稿；方法;验证;可视化;写作——审阅和编辑；正式的分析。Jente Simoens：方法论；验证;软件。Andreas Polydorou：调查；验证;监督。Pieter De Backer：概念化；方法;验证;软件;正式的分析;数据管理。Alex motrie：方法论；验证;软件;监督。没有使用任何资金。作者之间无利益冲突。这项研究是按照1964年《赫尔辛基宣言》及其后来的修正案的道德标准进行的。
{"title":"World's first live AI-assisted augmented reality (AR) robotic colon surgery with instrument deocclusion: Navigating the future of surgery","authors":"Thalia Petropoulou, Jente Simoens, Andreas Polydorou, Pieter De Backer, Alex Mottrie","doi":"10.1111/codi.70296","DOIUrl":"10.1111/codi.70296","url":null,"abstract":"<p>Artificial intelligence (AI) and augmented reality (AR) are transforming the landscape of minimally invasive surgery. We present the world's first live integration of an AI-assisted AR overlay with real-time instrument deocclusion in robotic colorectal surgery.</p><p>A real surgical case of robotic right colectomy was performed using a da Vinci Xi platform enhanced by an AI-driven AR system. The technology generated three-dimensional anatomical overlays while simultaneously applying instrument deocclusion algorithms to maintain continuous visualization of critical anatomy (Video 1).</p><p>The procedure was successfully completed without conversion, demonstrating the technical feasibility of combining AI-based overlays and deocclusion in a complex intraoperative environment. The system allowed stable AR guidance despite dynamic camera movements and instrument interference. From the operating surgeon's perspective, the AR overlay was useful, non-disruptive to workflow, and enhanced anatomical orientation. These impressions are preliminary and require validation in prospective studies.</p><p>This proof-of-concept highlights the feasibility of AI-assisted AR with instrument deocclusion in robotic colorectal surgery and represents an important step toward digital surgery of the future. While no formal outcomes or structured user assessments were collected in this initial demonstration, future studies will focus on systematic evaluation of usability, surgeon feedback, and clinical performance metrics.</p><p><b>Thalia Petropoulou:</b> Conceptualization; investigation; writing – original draft; methodology; validation; visualization; writing – review and editing; formal analysis. <b>Jente Simoens:</b> Methodology; validation; software. <b>Andreas Polydorou:</b> Investigation; validation; supervision. <b>Pieter De Backer:</b> Conceptualization; methodology; validation; software; formal analysis; data curation. <b>Alex Mottrie:</b> Methodology; validation; software; supervision.</p><p>No funding was used.</p><p>No conflict of interest between the authors.</p><p>This study was conducted in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 11","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/codi.70296","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145488075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号